🇺🇸 FDA

Intelligence Platform

Patents

Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8901095

Selective inhibition of polyglutamine protein expression

The Board of Regents of the University of Texas System · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8895717

Delivery of siRNA by neutral lipid compositions

The Board of Regents of the University of Texas System · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8895072

Quantum dot barcode structures and uses thereof

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8889623

Immunostimulatory nanoparticles and related compositions, methods and systems

The Board of Regents of the University of Texas System · Granted Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8889743

Inhibition of filovirus entry into cells and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8889121

Bacterium comprising a regulated rfaH nucleic acid

The Arizona Board of Regents for an on Behalf of Arizona State University · Granted Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8883174

Compositions for stimulation of mammalian innate immune resistance to pathogens

The Board of Regents of the University of Texas System · Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8883841

Oncogenic ras-specific cytotoxic compound and methods of use thereof

The Board of Regents of the University of Texas System · Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8883729

Nanolipoprotein particles and related compositions, methods and systems

The Board of Regents of the University of Texas System · Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8883154

Antibody-mediated modulation of allergy

The Board of Regents of the University of Texas System · Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8877188

Detection and treatment of non-dermal fibrosis

The Board of Regents of the University of Texas System · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8877797

Methods for treating Parkinson's disease using pro-neurogenic compounds

The Board of Regents of the University of Texas System · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8877215

Compounds with modifying activity enhanced under hypoxic conditions

The Board of Regents of the University of Texas System · Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8871794

Small-molecule agonists for type-2 orexin receptor

The Board of Regents of the University of Texas System · Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8865199

Biomatrix composition and methods of biomatrix seeding

The Board of Regents of the University of Texas System · Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8865187

Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract

The Board of Regents of the University of Texas System · Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8859736

Monoclonal antibodies that inhibit the wnt signaling pathway and methods of production and

The Board of Regents of the University of Oklahoma · Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8859727

Bioactive FUS1 peptides and nanoparticle-polypeptide complexes

The Board of Regents of the University of Texas System · Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8846859

Compositions and methods of use of targeting peptides against placenta and adipose tissues

The Board of Regents of the University of Texas System · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8846006

MRI markers, delivery and extraction systems, and methods of manufacture and use thereof

The Board of Regents of the University of Texas System · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8841257

Inhibitors of STAT3 and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8841273

Methods and compositions for anti-EGFR treatment

The Board of Regents of the University of Texas System · Granted Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8834938

Use of arsenic for cancer therapy protection

The Board of Regents of the University of Texas System · Granted Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8835493

Oligo-benzamide compounds for use in treating cancers

The Board of Regents of the University of Texas System · Granted Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted